Newer drug treatments for type 2 diabetes

BMJ. 2021 May 11:373:n1171. doi: 10.1136/bmj.n1171.

Authors

Jingchuan Guo¹, Steven M Smith^{2

3}

Affiliations

¹ Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA.
² Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA ssmith@cop.ufl.edu.
³ Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, USA.

PMID: 33975861
DOI: 10.1136/bmj.n1171

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Consensus Development Conferences as Topic
Diabetes Mellitus, Type 2 / drug therapy*
Glucagon-Like Peptide-1 Receptor / agonists
Glucagon-Like Peptide-1 Receptor / therapeutic use*
Humans
Sodium-Glucose Transporter 2 / therapeutic use*

Substances

Glucagon-Like Peptide-1 Receptor
SLC5A2 protein, human
Sodium-Glucose Transporter 2